Depo-Provera MDL 3140 Explained: What It Is, How It Works, and What to Expect

Published: March 20, 2026 9 min read

If you've been researching the Depo-Provera lawsuit, you've run into the term "MDL 3140" and maybe wondered what it actually means. MDL stands for multidistrict litigation — a federal process for handling large numbers of related lawsuits in one court. Here's how MDL 3140 works, what the timeline looks like, and what it means if you're thinking about filing a claim.

What Is an MDL? A Plain English Explanation

Imagine that 5,000 women across the country all file separate lawsuits against Pfizer claiming that Depo-Provera caused their meningioma. If each case proceeded independently in 5,000 different courts, both sides would have to hire separate legal teams for each case, present the same expert witnesses 5,000 times, and make the same arguments about the science repeatedly in courts from Florida to Alaska. It would be chaotic and massively inefficient.

A multidistrict litigation (MDL) solves this problem. Under 28 U.S.C. § 1407, when multiple federal cases involve common questions of fact, the Judicial Panel on Multidistrict Litigation (JPML) can consolidate them in a single district court for coordinated pretrial proceedings. One federal judge manages all the cases together for discovery, motion practice, and pretrial proceedings.

Important: consolidation does not mean all cases merge into one. Each plaintiff still has their own individual claim. The MDL is a coordination mechanism, not a merger. If cases don't settle, they can be "remanded" (sent back) to their original districts for trial.

MDL vs. Class Action: Why This Matters to You

Many people confuse MDLs and class actions. They are fundamentally different, and the difference affects your rights.

In a class action, all plaintiffs are treated as one group. If the class wins, the recovery is divided among all class members — often resulting in small individual payouts. You typically don't negotiate your individual damages. You're automatically included unless you opt out.

In an MDL, your case remains individual. You have your own attorney. Your specific damages — your medical bills, your lost income, your particular tumor severity — are individually evaluated in settlement negotiations. Higher damages cases tend to get larger settlements. You are not automatically grouped with everyone else. This generally results in more individualized, and often larger, recoveries for the most seriously injured plaintiffs.

The Depo-Provera litigation is an MDL, not a class action. For more detail on this distinction, see: Depo-Provera Class Action vs. MDL: What's the Difference?

Depo-Provera MDL 3140: The Basics

MDL 3140 was created after the FDA issued its August 2024 black box warning connecting Depo-Provera to meningioma — a type of brain tumor. The JPML received petitions from plaintiffs across multiple states and determined that consolidation in the Northern District of Illinois made sense given the concentration of filed cases and the court's capacity.

How Depo-Provera MDL 3140 Works: Step by Step

1. Plaintiffs' Steering Committee (PSC) Formation

Early in the MDL, Judge Lee appointed a Plaintiffs' Steering Committee — a group of experienced mass tort attorneys selected to coordinate litigation strategy on behalf of all plaintiffs. These are the lead attorneys who argue the common issues, take the big depositions, hire shared expert witnesses, and negotiate with Pfizer's legal team.

Your individual attorney remains your personal lawyer and advocate, but the PSC does the heavy lifting on the shared legal work that benefits everyone.

2. Plaintiff Fact Sheets

The court requires every plaintiff to complete a Plaintiff Fact Sheet (PFS) — a detailed questionnaire documenting your Depo-Provera use, medical history, treatment, and damages. This standardizes information collection across thousands of cases and gives both sides the data they need to sort cases into groups.

3. Common Discovery

Discovery in an MDL is divided into "common" and "case-specific" discovery. Common discovery covers issues affecting all plaintiffs: depositions of Pfizer executives and scientists, production of Pfizer's internal documents about what they knew about meningioma risk, development of shared expert testimony on causation. This work is done by the PSC and benefits all plaintiffs simultaneously.

4. Bellwether Trial Selection

After common discovery is substantially complete, the parties select a small number of "bellwether" cases — typically 10 to 20 — that go to trial first. These cases are chosen to represent the range of plaintiff experiences (different use durations, different tumor types, different states). The verdicts in bellwether trials give both sides real data about how juries respond to the evidence.

5. Bellwether Trials

The selected cases go to trial. In the Depo-Provera MDL, first bellwether trials are anticipated for late 2026 or 2027. These are real trials with real juries. If plaintiff verdicts come in, it signals liability and helps set the range for global settlement.

6. Global Settlement Negotiations

After bellwether results, the parties typically enter serious settlement negotiations. The defendant (Pfizer/Pharmacia) and the PSC negotiate a global settlement framework that assigns values to different categories of cases based on factors like use duration, tumor severity, treatment required, and demonstrated damages. Individual attorneys then present their clients' cases within that framework to determine specific recovery amounts.

7. Individual Settlements

Once a settlement framework is in place, individual cases are resolved. You and your attorney negotiate whether the settlement offer for your specific case is fair. You can accept or reject the offer — you are not required to settle.

MDL 3140 Litigation Timeline

Based on comparable pharmaceutical MDLs, here is a realistic timeline for Depo-Provera MDL 3140:

• 2024 (complete): FDA black box warning → MDL formation → PSC appointment
• 2025 (complete): Case growth → Plaintiff fact sheets → Common discovery begins
• Early 2026 (ongoing): Bellwether pool selection → Expert reports served
• Mid-to-late 2026: Daubert hearings (expert challenges) → First bellwether trials possible
• 2027: Bellwether verdicts → Settlement negotiations begin in earnest
• 2027–2028: Global settlement framework negotiated and announced
• 2028–2029: Individual claim administration and payouts

This timeline can compress if trials go well for plaintiffs early, or extend if there are major discovery disputes or appeals. It's not an exact prediction — it's a realistic range based on how comparable litigation has moved.

Your Role as a Plaintiff in MDL 3140

Being a plaintiff in MDL 3140 doesn't mean you'll be in the courtroom. Your day-to-day role is primarily:

• Completing your Plaintiff Fact Sheet accurately and thoroughly
• Providing medical records and authorizing record releases
• Staying in communication with your attorney — respond to their requests promptly
• Potentially participating in a deposition (answering questions under oath about your experience) — not all plaintiffs are deposed, but it's possible
• Making settlement decisions — ultimately, whether to accept a settlement is your decision, not your attorney's

Your attorney handles the actual litigation work. Your job is to provide the facts and medical documentation that supports your claim.

How Settlement Works in a Mass Tort MDL

Settlement in a pharmaceutical MDL works differently from how most people picture a legal settlement. There is no single moment where Pfizer writes one check for all plaintiffs. Instead:

A settlement fund or framework is negotiated globally. The PSC and Pfizer's counsel agree on a total amount available for settlement and a points- or tier-based system for distributing it based on claim characteristics (use duration, injury severity, documented damages, etc.).

Your individual case is valued within that framework. A claims administrator applies the framework to your specific facts and produces a settlement offer for your case.

You decide whether to accept. You and your attorney review the offer. If it's fair compensation for your damages, you accept. If not, you have options including negotiation or, in some cases, opting out and pursuing your case independently (though this is rare and risky).

Attorney fees come out of the settlement. Your attorney's contingency fee is deducted from your settlement amount, not paid separately by you.

For more on what settlements may look like financially, see: Depo-Provera Settlement Amounts: What to Expect.